Skip to main content

Conmed Value Stock - Dividend - Research Selection


ISIN: US2074101013 , WKN: 886793

Market price date:
Market price:  

Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Key figures
Cash flow
Balance sheet
Income statement
Div. Yield%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization USD
Raw Data Source
Stock Split

Description of the company

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors; and uterine manipulator (VCARE) for use in increasing the efficiency of laparoscopic hysterectomies and other gynecologic laparoscopic procedures. In addition, it offers general surgery product in the areas of endoscopic technologies, including minimally invasive diagnostic and therapeutic products; critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician\'s office electrosurgical product used by dermatologists. The company\'s products are used by surgeons and physicians in orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,


Is There An Opportunity With CONMED Corporation's (NYSE:CNMD) 44% Undervaluation?

Key Insights Using the 2 Stage Free Cash Flow to Equity, CONMED fair value estimate is US$194 CONMED is estimated to be...

Here's Why You Should Retain CONMED (CNMD) Stock for Now

CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.

CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference

LARGO, Fla., November 13, 2023--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Piper Sandler Healthcare Conference at 9:00 a.m. ET on Tuesday, November 28, 2023.

CONMED Corporation to Participate in Fireside Chats at Two Investor Conferences on November 14-15

LARGO, Fla., October 31, 2023--CONMED Corporation (NYSE: CNMD) today announced that it will participate in fireside chats at the following two investor conferences in November:

Analysts Are Bullish on These Healthcare Stocks: Conmed (CNMD), Resmed (RMD)

Looking for stock market analysis and research with proves results? offers in-depth financial research with over 30years of proven results.

The Conmed Corp (CNMD) Company: A Short SWOT Analysis

Unveiling the Strengths, Weaknesses, Opportunities, and Threats of Conmed Corp (CNMD) in Q3 2023

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Conmed posted another strong quarter, with low double-digit growth and operating margin leverage. Read more about CNMD stock here.

CONMED Corporation (NYSE:CNMD) Q3 2023 Earnings Call Transcript

CONMED Corporation (NYSE:CNMD) Q3 2023 Earnings Call Transcript October 25, 2023 CONMED Corporation beats earnings expectations. Reported EPS is $0.9, expectations were $0.83. Operator: Thank you for standing by. And welcome to CONMED’s Q3 Fiscal Year 2023 Earnings Call. At this time all participants are in a listen-only mode. [Operator Instructions] Before the conference call […]

Piper Sandler Maintains Conmed (CNMD) Overweight Recommendation


Needham Maintains Conmed (CNMD) Buy Recommendation